Phase 2 Data Continues to Support Remetinostat in Easing Itching in Early Stage Mycosis Fungoides
News
Topical remetinostat gel significantly reduces itching in patients with a kind of cutaneous T-cell lymphoma called mycosis fungoides, data from a Phase 2 trial shows. The medicine also reduced the ... Read more